51 related articles for article (PubMed ID: 8691251)
1. Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT.
Holle LH; Trampert L; Lung-Kurt S; Villena-Heinsen CE; Püschel W; Schmidt S; Oberhausen E
J Nucl Med; 1996 Apr; 37(4):615-22. PubMed ID: 8691251
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
3. [Tumor diagnosis using 18F-FDG SPECT].
Sugiyama S; Suzuki Y; Matsuzaki H; Tomiyoshi K; Endo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Aug; 56(9):679-80. PubMed ID: 8831228
[TBL] [Abstract][Full Text] [Related]
4. Breast imaging with fluorine-18-FDG PET: quantitative image analysis.
Avril N; Bense S; Ziegler SI; Dose J; Weber W; Laubenbacher C; Römer W; Jänicke F; Schwaiger M
J Nucl Med; 1997 Aug; 38(8):1186-91. PubMed ID: 9255146
[TBL] [Abstract][Full Text] [Related]
5. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
Martin WH; Delbeke D; Patton JA; Sandler MP
Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
[TBL] [Abstract][Full Text] [Related]
6. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
[TBL] [Abstract][Full Text] [Related]
7. FDG-SPECT: correlation with FDG-PET.
Martin WH; Delbeke D; Patton JA; Hendrix B; Weinfeld Z; Ohana I; Kessler RM; Sandler MP
J Nucl Med; 1995 Jun; 36(6):988-95. PubMed ID: 7769457
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography.
Worsley DF; Celler A; Adam MJ; Kwong JS; Müller NL; Coupland DB; Champion P; Finley RJ; Evans KG; Lyster DM
AJR Am J Roentgenol; 1997 Mar; 168(3):771-4. PubMed ID: 9057532
[TBL] [Abstract][Full Text] [Related]
9. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
Drane WE; Abbott FD; Nicole MW; Mastin ST; Kuperus JH
Radiology; 1994 May; 191(2):461-5. PubMed ID: 8153322
[TBL] [Abstract][Full Text] [Related]
10. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.
Avril N; Dose J; Jänicke F; Bense S; Ziegler S; Laubenbacher C; Römer W; Pache H; Herz M; Allgayer B; Nathrath W; Graeff H; Schwaiger M
J Clin Oncol; 1996 Jun; 14(6):1848-57. PubMed ID: 8656253
[TBL] [Abstract][Full Text] [Related]
11. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
[TBL] [Abstract][Full Text] [Related]
12. Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
Hunter GJ; Choi NC; McLoud TC; Fischman AJ
J Nucl Med; 1993 Sep; 34(9):1571-3. PubMed ID: 8394885
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.
Adler LP; Crowe JP; al-Kaisi NK; Sunshine JL
Radiology; 1993 Jun; 187(3):743-50. PubMed ID: 8497624
[TBL] [Abstract][Full Text] [Related]
14. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
15. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Gritters LS; Francis IR; Zasadny KR; Wahl RL
J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M
J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038
[TBL] [Abstract][Full Text] [Related]
17. SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG).
Drane WE; Nicole MW; Mastin ST; Kuperus JH
Radiology; 1995 Nov; 197(2):341-2; discussion 343. PubMed ID: 7480674
[No Abstract] [Full Text] [Related]
18. Stereotactic coordinates from ECT sinograms for radionuclide-guided breast biopsy.
Raylman RR; Ficaro EP; Wahl RL
J Nucl Med; 1996 Sep; 37(9):1562-7. PubMed ID: 8790219
[TBL] [Abstract][Full Text] [Related]
19. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
[TBL] [Abstract][Full Text] [Related]
20. [The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers].
Xing Y; Zhao JH; Wang TS; Qiao WL; Che WJ
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):129-33. PubMed ID: 19538891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
